Name: LinkedIn · Clinical Trials
Creator: LinkPost

LinkPost - Tendance LinkedIn : Clinical Trials · analyse, évolution & top posts | LinkPost

Top posts sur ce sujet

D
Daphne Koller
Founder and CEO, insitro. Co-founder, Coursera. Professor of CS & Pathology at Stanford (now adjunct).
27 juin 2026
The FDA's Operation TrialBlazer is a serious and welcome initiative — streamlining IND submissions, enabling real-time data sharing, and continuing the transition away from less-than-predictive animal models. The backdro…
165652
LinkedIn
S
Sophie Adenot
European Space Agency Astronaut
19 juin 2026
[🇫🇷 version FR 👇] Day 126, orbit 1954 — Bone is a living tissue: to stay strong, it needs to feel the steady pull of gravity when we stand, move, and exercise. Take that away, and it weakens fast – one of the reasons …
92017
LinkedIn
J
Jorge Reis-Filho
Chief of AI for Science Innovation, Enterprise AI Unit, AstraZeneca
22 juil. 2026
Yesterday, I had the immense pleasure of meeting Hannah Amies, Co-founder and CEO of Luvida, for a fascinating discussion centered around the ways AI can fundamentally reimagine clinical trials through a focus on underst…
78020
LinkedIn
P
Pierre ETIENNE
Pédopsychiatre
26 mai 2026
💊 Ce que les études disent vraiment sur les antidépresseurs Pendant des années, le grand public a entendu une idée devenue presque évidente : 👉 la dépression serait essentiellement liée à un “déséquilibre chimique”, n…
51131
LinkedIn
R
Roy de Souza
Drugs designed with AI per person then manufactured. To cure solid cancers regardless of type. Treating a few patients on compassionate use. FDA approved trials starting.
7 juil. 2026
When I founded BreakBio Corp 7 years ago, most people thought I was naive. Few believed the FDA would be supportive of drugs designed and manufactured per person. But … The current FDA has decided to be proactive and t…
45471
LinkedIn
D
Dr Riadh Caïd-Essebsi
Chef du pôle médecine 2- Hôpital américain de Paris - Ancien président du conseil médical
7 juil. 2026
50 ans 95 kg. 1m78. IMC à 30, pile la frontière de l’obésité. Tension normale, glycémie normale, bilan lipidique presque normal. Ce patient se sent bien, il n’a rien demandé. Il vient me voir parce que son médecin …
35147
LinkedIn
S
Steve Suarez®
Chief Executive Officer | Entrepreneur | Board Member | Senior Advisor McKinsey | Harvard & MIT Alumnus | Ex-HSBC | Ex-Bain
2 juil. 2026
Drug discovery takes 6 to 7 years, but quantum computing could cut that to just 1. The prize is up to $400B in value for pharma by 2035. The pharmaceutical industry spends roughly 22 percent of its revenue on research a…
34918
LinkedIn
R
Reza Hosseini Ghomi, MD, MSE
Neuropsychiatrist | Engineer | 4x Health Tech Founder | Cancer Graduate | Keynote Speaker on Brain Health, AI in Medicine & Healthcare Innovation - Follow to Unlock Potential
13 juil. 2026
Ozempic lowered brain inflammation exactly as promised. The patients got worse anyway. Novo Nordisk ran two of the largest Alzheimer's trials ever attempted. Nearly 3,800 patients. Two years. The most famous drug in th…
313174
LinkedIn
A
Adam Steensberg, MD, MBA
President and CEO at Zealand Pharma
2 juin 2026
A year in with our partners Roche and Genentech. Great conversations recently with Teresa Harris Graham and Ashley Magargee on where we've been and where we're going. Two companies, one shared obsession with finding a be…
2612
LinkedIn
J
Jan Beger
Our conversations must move beyond algorithms.
29 mai 2026
Ten AI capabilities in precision oncology, mapped end-to-end from screening to drug design, reveal how much clinical-grade AI already exists and how little of it has reached formal trial validation. 1️⃣ Cancer's global …
2304
LinkedIn

Une question ?

Salut !

Une question ?

Salut !

Clinical Trials

Évolution sur 12 semaines

Top posts sur ce sujet